Home›Companies›Healthcare›Samothrace Medical Innovations

Samothrace Medical Innovations Inc.

Develops minimally invasive devices for diagnosing and treating bowel disease.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Aug 21, 2026·Suggest an edit

About Samothrace Medical Innovations

Samothrace Medical Innovations is a private company based in Daniel Island, South Carolina, incorporated in 2022 in Delaware. It has reported $5,204,000 raised in one offering on Form D since August 2026. Its chief executive is John DeFord.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 29, 2026Aug 21, 2026$5,204,000of $8.6M target23$226KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Samothrace Medical Innovations's Form D filed Aug 21, 2026.

JD
John DeFord
Co-founder, CEO and Chairman of the Board
Also a director at Enable Injections.
GK
Ghassan Kassab
Co-founder, Board Member
MB
Michael Bunker
Director
Also a director at ValCor Cath.

Sources

  1. SECSamothrace Medical Innovations Inc. filing history
  2. CompanySamothrace Medical Innovations team